A detailed history of Mba Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mba Advisors LLC holds 4,504 shares of MRK stock, worth $457,696. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,504
Previous 4,520 0.35%
Holding current value
$457,696
Previous $559,000 8.59%
% of portfolio
0.25%
Previous 0.29%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$111.15 - $128.97 $1,778 - $2,063
-16 Reduced 0.35%
4,504 $511,000
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $495 - $531
4 Added 0.09%
4,520 $559,000
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $37,822 - $44,071
-334 Reduced 6.89%
4,516 $595,000
Q4 2023

Jan 19, 2024

BUY
$100.18 - $109.02 $2,504 - $2,725
25 Added 0.52%
4,850 $528,000
Q3 2023

Oct 19, 2023

BUY
$102.95 - $114.33 $411 - $457
4 Added 0.08%
4,825 $496,000
Q2 2023

Jul 21, 2023

SELL
$108.61 - $118.38 $41,706 - $45,457
-384 Reduced 7.38%
4,821 $556,000
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $1,441 - $1,608
-14 Reduced 0.27%
5,205 $553,000
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $437 - $560
5 Added 0.1%
5,219 $0
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $422 - $474
5 Added 0.1%
5,214 $449,000
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $417 - $473
5 Added 0.1%
5,209 $475,000
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $135,625 - $152,028
-1,845 Reduced 26.17%
5,204 $427,000
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $134,079 - $167,951
1,855 Added 35.71%
7,049 $540,000
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $358 - $394
5 Added 0.1%
5,194 $390,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $351 - $388
5 Added 0.1%
5,189 $404,000
Q1 2021

May 18, 2021

BUY
$68.86 - $81.11 $356,970 - $420,474
5,184 New
5,184 $400,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mba Advisors LLC Portfolio

Follow Mba Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mba Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mba Advisors LLC with notifications on news.